| Ticker Symbol: | MRK |
|---|---|
| Exchange: | NYSE |
| Contact Info: | One Merck Drive Whitehouse Station NJ 08889-0100 908 423-1000 |
| CEO/President: | David W. Anstice |
| Industry: | Medical - Drugs / Standard Industry Code: 2834 |
| Description: | Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reac |
| Shares Outstanding: | 2,146,530 (000) | Market Value: | 82,534,008 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 70.67% | Number of Inst.Shareholders: | 0.32% |
| Last Quarter Sales: | N/C ($Mil.) | Last Quarter Net Income: | N/C ($Mil.) |
| Last Quarter EPS: | N/C | P/E Ratio: | 11 |
| Most Recent Earnings: | 0.89 on 04/21/08 | Earnings Per Share: | 1.47 |
| Most Recent Split: | 2-1 on 02/17/99 | Annual Dividend Rate: | 1.52 |
| Most Recent Dividend: | 0.380 on 06/04/08 | Annual Dividend Yield: | 3.95% |


| PFIZER INC | -27.40 | 18.19 | |
| MERCK CO INC | -29.50 | 36.97 | |
| BRISTOL MYERS S | -27.00 | 21.65 | |
| SCHERING PLOUGH | -28.40 | 20.86 | |
| WYETH | -0.90 | 49.48 |
